Lyra Therapeutics Inc
(OTCPK:LYRA)
$
0.25
-0.030 (-10.71%)
Market Cap: 444,000.00
Enterprise Value: 14.81 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 29/100 Lyra Therapeutics Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 04:25PM GMT
Release Date Price:
$195
(+1.04%)
Chris Howerton
Jefferies LLC - Analyst
My name is Chris Howerton, part of the Jefferies biotechnology research team. I am thrilled to be hosting a fireside chat with Lyra Therapeutics, and on behalf of the company, we have the CEO, Dr. Maria Palasis. So thank you so much for joining us, Maria.
Maria Palasis
Lyra Therapeutics, Inc. - CEO, President
Hi, Chris. It's good to be here in London with you.
Chris Howerton
Jefferies LLC - Analyst
Absolutely. I think this is the first time I've been back in two years. So it's nice to see you in person.
Maria Palasis
Lyra Therapeutics, Inc. - CEO, President
Yeah, yeah.
Questions & Answers
Chris Howerton;Maria Palasis
Jefferies LLC - Analyst;Lyra Therapeutics,
All right. So I guess maybe for those that are not totally oriented to the Lyra story, what could you tell us or how would you describe the lead indication of chronic rhinosinusitis?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot